Figure 4
Figure 4. TMD-tail mini-integrins activate native integrin αIIbβ3. (A) Tac-αIIbTM or Tac-αIIb was transfected into CHO cells expressing αIIbβ3 (A5 cells). Twenty-four hours after transfection, cells were stained with PAC1 (activation-specific anti-αIIbβ3 antibody) and 7G7B6 (anti-Tac antibody) in the presence or absence of a selective inhibitor of ligand binding to αIIbβ3, Ro-43-5054, and then analyzed by flow cytometry to generate the dot plots shown (left). Geometric means of PAC1 binding in cells expressing different quantities of Tac constructs were plotted as larger red dots. Specific PAC1 binding was calculated by subtracting the geometric means of PAC1 binding in the presence of Ro-43-5054 from that in the absence of Ro-43-5054 in each range, and plotted as a line graph (right). (B) The effects of Tac-αIIbTMΔGFFKR and Tac-αIIbTMLXXXL on αIIbβ3 activation were analyzed, as in panel A. (C) The effects of Tac-β3TM, Tac-β3, and Tac-β3TM(Y747A) on αIIbβ3 activation were analyzed, as in panel A. The activating effects of each Tac constructs were tested at least 3 times, and representative data are shown.

TMD-tail mini-integrins activate native integrin αIIbβ3. (A) Tac-αIIbTM or Tac-αIIb was transfected into CHO cells expressing αIIbβ3 (A5 cells). Twenty-four hours after transfection, cells were stained with PAC1 (activation-specific anti-αIIbβ3 antibody) and 7G7B6 (anti-Tac antibody) in the presence or absence of a selective inhibitor of ligand binding to αIIbβ3, Ro-43-5054, and then analyzed by flow cytometry to generate the dot plots shown (left). Geometric means of PAC1 binding in cells expressing different quantities of Tac constructs were plotted as larger red dots. Specific PAC1 binding was calculated by subtracting the geometric means of PAC1 binding in the presence of Ro-43-5054 from that in the absence of Ro-43-5054 in each range, and plotted as a line graph (right). (B) The effects of Tac-αIIbTMΔGFFKR and Tac-αIIbTMLXXXL on αIIbβ3 activation were analyzed, as in panel A. (C) The effects of Tac-β3TM, Tac-β3, and Tac-β3TM(Y747A) on αIIbβ3 activation were analyzed, as in panel A. The activating effects of each Tac constructs were tested at least 3 times, and representative data are shown.

Close Modal

or Create an Account

Close Modal
Close Modal